Northern Trust’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-1,285,915
Closed -$31M 4404
2014
Q2
$31M Sell
1,285,915
-71,998
-5% -$751K 0.01% 1165
2014
Q1
$8.19M Sell
1,357,913
-38,023
-3% -$265K ﹤0.01% 2247
2013
Q4
$8.35M Buy
1,395,936
+16,971
+1% +$78.5K ﹤0.01% 2206
2013
Q3
$7.16M Buy
1,378,965
+75,857
+6% +$332K ﹤0.01% 2256
2013
Q2
$4.7M Buy
+1,303,108
New +$5.33M ﹤0.01% 2462

Northern Trust's IDIX Position: Q3 2014 in Review

Northern Trust sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 1,285,915 shares — an estimated $31M sold.

Northern Trust first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $31M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Northern Trust reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Northern Trust sold 1,285,915 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $31M.
  • Northern Trust first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Northern Trust's IDENIX PHARMACEUTICALS INC position peaked at $31M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Northern Trust's 13F filing for Q3 2014, filed 13 Nov 2014.